The aim of this study was to determine the retinal content of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1α (HIF-1α) in experimental diabetic retinopathy and to assess the effect of pharmacological blockade of cellular protein kinases with sorafenib on these parameters. Here, VEGFA is linked to diabetic retinopathy.